---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-017833"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2026-04-17T23:59:59+00:00"
generated_at: "2026-05-15T05:28:03.602724+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lixte Biotechnology cancels 500,000 options, awards equal RSUs vesting immediately to CEO, CFO, and directors

## Summary
- CEO Geordan Pursglove: 350,000 options cancelled, 350,000 RSUs awarded; CFO Peter Stazzone: 50,000 each.
- Directors Holloway, Primus, Felix, Sawyer: each 25,000 options cancelled and RSUs awarded.
- RSUs granted under 2020 Stock Incentive Plan and vested immediately on April 15, 2026.
- Committee states swap provides better retention/incentive for officers and directors.

## SEC filing metadata
- accession: 0001493152-26-017833
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2026-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315226017833/0001493152-26-017833-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315226017833/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-017833
- JSON: https://secwatch.observer/filing/0001493152-26-017833.json
- Plain text: https://secwatch.observer/filing/0001493152-26-017833.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.